Evidence map›Paper›PMID 36394032›Full record

ArticleFrontiers in bioengineering and biotechnology2022

New self-sexing

Siân A M Spinner, Zoe H Barnes, Alin Mirel Puinean, Pam Gray, Tarig Dafa'alla, Caroline E Phillips, Camila Nascimento de Souza, Tamires Fonseca Frazon, Kyla Ercit, Amandine Collado and 12 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Copy Number Variation-Based Molecular Sexing ofbioRxiv : the preprint server for biology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Differential elimination of marked sex chromosomes enables production of nontransgenic male mosquitoes in a single strain.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. ExploitingPathogens (Basel, Switzerland) · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 1 institution in 1 country.

Siân A M SpinnerOxitec Ltd., Abingdon, United Kingdom.
Zoe H BarnesOxitec Ltd., Abingdon, United Kingdom.
Alin Mirel PuineanOxitec Ltd., Abingdon, United Kingdom.
Pam GrayOxitec Ltd., Abingdon, United Kingdom.
Tarig Dafa'allaOxitec Ltd., Abingdon, United Kingdom.
Caroline E PhillipsOxitec Ltd., Abingdon, United Kingdom.
Camila Nascimento de SouzaOxitec Ltd., Abingdon, United Kingdom.
Tamires Fonseca FrazonOxitec Ltd., Abingdon, United Kingdom.
Kyla ErcitOxitec Ltd., Abingdon, United Kingdom.
Amandine ColladoOxitec Ltd., Abingdon, United Kingdom.
Neil NaishOxitec Ltd., Abingdon, United Kingdom.
Edward SulstonOxitec Ltd., Abingdon, United Kingdom.
Gwilym C Ll PhillipsOxitec Ltd., Abingdon, United Kingdom.
Kelleigh K GreeneOxitec Ltd., Abingdon, United Kingdom.
Mattia PolettoOxitec Ltd., Abingdon, United Kingdom.
Benjamin D SperryOxitec Ltd., Abingdon, United Kingdom.
Simon A WarnerOxitec Ltd., Abingdon, United Kingdom.
Nathan R RoseOxitec Ltd., Abingdon, United Kingdom.
Grey K FrandsenOxitec Ltd., Abingdon, United Kingdom.
Natalia C VerzaOxitec Ltd., Abingdon, United Kingdom.
Kevin J GormanOxitec Ltd., Abingdon, United Kingdom.
Kelly J MatzenOxitec Ltd., Abingdon, United Kingdom.
Oxitec (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For more than 60 years, efforts to develop mating-based mosquito control technologies have largely failed to produce solutions that are both effective and scalable, keeping them out of reach of most governments and communities in disease-impacted regions globally. High pest suppression levels in trials have yet to fully translate into broad and effective

Indexed as

Aedes aegyptigenetic sexingself-limiting insectssustainabilityvector control

Identifiers

PMID36394032
PMCPMC9650594
OpenAlexW4308168455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.